TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

Yuan et al. (Fri,) studied this question.

www.synapsesocial.com/papers/69d7335cb54ccf0cfef30782 — DOI: https://doi.org/10.1097/js9.0000000000000256

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)· 2008 · 29,282 citations
2. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery· 2021 · 2,133 citations
3. Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival· 2011 · 308 citations
4. Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study· 2021 · 133 citations
5. Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study· 2022 · 180 citations